Allurion Technologies, Inc. (ALUR) - Total Assets
Based on the latest financial reports, Allurion Technologies, Inc. (ALUR) holds total assets worth $18.14 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Allurion Technologies, Inc. service its debt to assess how comfortably operating cash covers total debt obligations.
Allurion Technologies, Inc. - Total Assets Trend (2020–2024)
This chart illustrates how Allurion Technologies, Inc.'s total assets have evolved over time, based on quarterly financial data. See Allurion Technologies, Inc. shareholders equity for net asset value and shareholders' equity analysis.
Allurion Technologies, Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Allurion Technologies, Inc.'s total assets of $18.14 Million consist of 82.8% current assets and 17.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 46.9% |
| Accounts Receivable | $7.13 Million | 21.7% |
| Inventory | $3.40 Million | 10.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Allurion Technologies, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ALUR company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Allurion Technologies, Inc.'s current assets represent 82.8% of total assets in 2024, an increase from 14.3% in 2020.
- Cash Position: Cash and equivalents constituted 46.9% of total assets in 2024, up from 14.3% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 21.7% of total assets.
Allurion Technologies, Inc. Competitors by Total Assets
Key competitors of Allurion Technologies, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.24 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Allurion Technologies, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.26 | 2.33 | 1.82 |
| Quick Ratio | 0.94 | 2.09 | 1.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.98 Million | $25.59 Million | $622.26K |
Allurion Technologies, Inc. - Advanced Valuation Insights
This section examines the relationship between Allurion Technologies, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.42 |
| Asset Growth Rate (YoY) | -54.2% |
| Total Assets | $32.81 Million |
| Market Capitalization | $13.77 Million USD |
Valuation Analysis
Below Book Valuation: The market values Allurion Technologies, Inc.'s assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Allurion Technologies, Inc.'s assets decreased by 54.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Allurion Technologies, Inc. (2020–2024)
The table below shows the annual total assets of Allurion Technologies, Inc. from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $32.81 Million | -54.24% |
| 2023-12-31 | $71.71 Million | +39.60% |
| 2022-12-31 | $51.37 Million | +30.54% |
| 2021-12-31 | $39.35 Million | +11825.81% |
| 2020-12-31 | $329.96K | -- |
About Allurion Technologies, Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehea… Read more